AspirinPractice Guidelines as TopicGuidelines as TopicGuideline AdherencePlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEvidence-Based MedicineTiclopidineThromboxane B2Societies, MedicalCyclooxygenase InhibitorsPlatelet AggregationHealth Planning GuidelinesSalicylatesPhysician's Practice PatternsPlatelet Function TestsDrug Therapy, CombinationTreatment OutcomeRisk FactorsUnited StatesFibrinolytic AgentsAnticoagulantsBlood PlateletsHemorrhageSodium SalicylateProspective StudiesTime FactorsWarfarinRisk AssessmentConsensusRetrospective StudiesAsthma, Aspirin-InducedGastrointestinal HemorrhageTablets, Enteric-CoatedDose-Response Relationship, DrugCyclooxygenase 1Randomized Controlled Trials as TopicQuestionnairesThrombosisBleeding TimePrimary PreventionProstaglandin-Endoperoxide SynthasesPlatelet ActivationIbuprofenQuality Assurance, Health CareThromboxanesDouble-Blind MethodStrokeFollow-Up StudiesMyocardial InfarctionThromboxane A2Cardiovascular DiseasesDecision Making, Computer-AssistedCyclooxygenase 2 InhibitorsMedical AuditGreat BritainDipyridamoleAcetaminophenDecision Support Systems, ClinicalCost-Benefit AnalysisAttitude of Health PersonnelDrug ResistanceNetherlandsCanadaDisease ManagementDrug UtilizationLipoxinsResearch DesignEuropeCohort StudiesDrug Administration ScheduleFamily PracticePrimary Health CareQuality ControlIndomethacinClinical Trials as TopicIncidenceMass ScreeningQuality of Health CareGastric MucosaClinical ProtocolsSulfinpyrazoneHealth Care SurveysRecurrenceStomach UlcerCyclooxygenase 2Patient SelectionReye SyndromePatient ComplianceDrug HypersensitivityPregnancyCardiologyProstaglandinsThromboembolismAnti-Bacterial AgentsHeparinReferral and ConsultationNaproxenAmerican Heart AssociationDrug Interactions